Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats

Growth Hormone and IGF Research

Volumn 9, Issue 1, 1999, Pages 74-80

  Skjærbæk, Christian ^a   Frystyk, Jan ^a   Grøfte, Thorbjørn ^a   Flyvbjerg, Allan ^a   Lewitt, Moira S ^b   Baxter, Robert C ^c   Ørskov, Hans ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Acid labile subunit; Catabolism; Free IGF I; Glucocorticoids; Growth; IGF binding proteins; IGF I; Methylprednisolone; Rats

Indexed keywords

GLUCOCORTICOID; GLUCOSE; METHYLPREDNISOLONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CATABOLISM; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

EID: 0033080846     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.1999.0090     Document Type: Article

References (39)

1. Horber F. F., Haymond M. W. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest. 86:1990;265-272.
2. Oehri M., Ninnis R., Girard J., Frey F. J., Keller U. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans. Am J Physiol. 270:1996;E552-E558.
3. Malmlöf K., Arrhenius Nyberg V., Saxerholt H., Skottner A. The role of insulin, insulin-like growth factor-I and growth hormone in counteracting dexamethasone induced nitrogen wasting in rats. Horm Metab Res. 29:1997;20-23.
4. Tomas F. M., Knowles S. E., Owens P. C. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem J. 282:1992;91-97.
5. Luo J. M., Murphy L. J. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology. 125:1989;165-171.
6. Burgin L., Iezzoni D., Gribetz D., Talbot N. B. Effects of prolonged cortisone therapy on the statural growth and skeletal maturation and metabolic status of children. N Engl J Med. 254:1956;636-641.
7. Loeb J. N. Corticosteroids and growth. N Engl J Med. 295:1976;547-552.
8. Miell J. P., Taylor A. M., Jones J. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol. 136:1993;525-533.
9. Miell J. P., Buchanan C. R., Norman M. R., Maheshwari H. G., Blum W. F. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. J Endocrinol. 142:1994;547-554.
10. Martul P., Pineda J., Dieguez C., Casanueva F. F. Corticoid-induced growth hormone (GH) secretion in GH-deficient and normal children. J Clin Endocrinol Metab. 75:1992;536-539.
11. Pralong F. P., Miell J. P., Corder R., Gaillard R. C. Dexamethasone treatment in man induces changes in 24-hour growth hormone (GH) secretion profile without altering total GH released. J Clin Endocrinol Metab. 73:1991;1191-1196.
12. Miell J. P., Corder R., Pralong F. P., Gaillard R. C. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers. J Clin Endocrinol Metab. 72:1991;675-681.
13. Green O. C., Winter R. J., Kawahara F. S. Pharmacokinetic studies of prednisolone in children. Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. J Pediatr. 93:1978;299-303.
14. Elders M. J., Wingfield B. S., McNatt M. L., Clarke J. S., Hughes E. R. Glucocorticoid therapy in children. Effect on somatomedin secretion. Am J Dis Child. 129:1975;1393-1396.
15. Unterman T. G., Phillips L. S. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab. 61:1985;618-626.
16. Taylor A. M., Dunger D. B., Preece M. A. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol Oxf. 32:1990;229-239.
17. Lewitt M. S., Denyer G. S., Cooney G. J., Baxter R. C. Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology. 129:1991;2254-2256.
18. Cox G. N., McDermott M. J., Merkel E. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology. 135:1994;1913-1920.
19. Rajkumar K., Barron D., Lewitt M. S., Murphy L. J. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology. 136:1995;4029-4034.
20. Frystyk J., Skjærbæk C., Dinesen B., Ørskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348:1994;185-191.
21. Ørskov H., Thomsen H. G., Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature. 219:1968;193-195.
22. Baxter R. C., Dai J. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology. 134:1994;848-852.
23. Lewitt M. S., Saunders H., Phuyal J. L., Baxter R. C. Regulation of insulin-like growth factor-binding protein-1 in rat serum. Diabetes. 43:1994;232-239.
24. Frystyk J., Baxter R. C. Competitive binding assay for determination of rat insulin-like growth factor binding protein 3. Endocrinology. 139:1998;1454-1457.
25. Frystyk J., Grønbæk H., Skjærbæk C., Flyvbjerg A. Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats. Am J Physiol. 269:1995;E840-E845.
26. Schoenle E., Zapf J., Humbel R. E., Froesch E. R. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 296:1982;252-253.
27. Wolthers O. D., Juul A., Hansen M., Muller J., Pedersen S. The insulin-like growth factor axis and collagen turnover during prednisolone treatment. Arch Dis Child. 71:1994;409-413.
28. Baxter R. C. Insulin-like growth factor binding proteins as glucoregulators. Metabolism. 44 (Suppl. 4):1995;12-17.
29. Frystyk J., Vestbo E., Skjærbæk C., Mogensen C. E., Ørskov H. Free insulin-like growth factors in human obesity. Metabolism. 44 (Suppl. 4):1995;37-44.
30. Frystyk J., Skjærbæk C., Alexander N. Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty. Circulation. 94:1996;2465-2471.
31. Brismar K., Grill V., Efendic S., Hall K. The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metabolism. 40:1991;728-732.
32. Luo J., Reid R. E., Murphy L. J. Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology. 127:1990;1456-1462.
33. Lewitt M. S., Saunders H., Baxter R. C. Interaction of insulin, glucocorticoids, and protein kinase C in the regulation of insulin-like growth factor-binding protein-1 production by H4IIE rat hepatoma cells. J Cell Physiol. 166:1996;121-129.
34. Conover C. A., Divertie G. D., Lee P. D. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol Copenh. 128:1993;140-143.
35. Lewitt M. S., Saunders H., Baxter R. C. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology. 133:1993;1797-1802.
36. Dai J., Baxter R. C. Regulationin vivo. Endocrinology. 135:1994;2335-2341.
37. Baxter R. C., Holman S. R., Corbould A., Stranks S., Ho P. J., Braund W. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab. 80:1995;2700-2708.
38. Daughaday W. H., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 10:1989;68-91.
39. Lund S., Flyvbjerg A., Holman G. D., Larsen F. S., Pedersen O., Schmitz O. Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle. Am J Physiol. 267:1994;E461-E466.